Rio Grande Regional Hospital Welcomes its First Baby of the Decade

Translate to Spanish or other 102 languages!

Melissa Yazmin Lopez, mother, baby boy Jose Emmanuel Vazquez, and Emmanuel Vasquez, father.
Melissa Yazmin Lopez, mother, baby boy Jose Emmanuel Vazquez, and Emmanuel Vasquez, father.

Mega Doctor News

- Advertisement -

McAllen, Texas – Rio Grande Regional Hospital welcomed its first baby of the decade, Jose Emmanuel Vasquez at 8:53 a.m. on Wednesday, January 1, 2020.

Dr. Lourdes Uribe, helped welcome healthy baby boy Jose Emmanuel who was 19” inches and weighed 6 pounds, 1 ounce.  Baby Jose Emmanuel is the son of Melissa and Emmanuel, and he has one older brother.

“My baby was due on January 20th, but I have been experiencing contractions for the last few days, and I had a feeling I would go into labor on New Year’s Eve,” said Melissa.  “I still can’t believe I went into labor this early, but we are we are very excited to have our baby with us, and now we have another special reason to celebrate the New Year.”

- Advertisement -

As a special token, Melissa and her family received a gift basket filled with baby essentials and other goody items from the hospital. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -